Tower Research Capital LLC (Trc) Geron Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Geron Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 10,027 shares of GERN stock, worth $36,698. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,027
Previous 127,564
92.14%
Holding current value
$36,698
Previous $540,000
91.67%
% of portfolio
0.0%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding GERN
# of Institutions
275Shares Held
491MCall Options Held
1.87MPut Options Held
690K-
Black Rock Inc. New York, NY46.6MShares$170 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY44.1MShares$161 Million3.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.4MShares$119 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA32.3MShares$118 Million2.04% of portfolio
-
State Street Corp Boston, MA29MShares$106 Million0.01% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.38B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...